# FDA Inspection 1008334 - Freeman- Oak Hill Health System IRB #1 - March 29, 2017

Source: https://www.keypedia.com/records/fda_inspections/freeman-oak-hill-health-system-irb-1/82e68a94-07ac-4dd2-a69d-b8d3436648fc
Source feed: FDA_Inspections

> FDA Inspection 1008334 for Freeman- Oak Hill Health System IRB #1 on March 29, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1008334
- Company Name: Freeman- Oak Hill Health System IRB #1
- Inspection Date: 2017-03-29
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 705762 - 2011-01-11](https://www.keypedia.com/records/fda_inspections/freeman-oak-hill-health-system-irb-1/d164627b-09db-4ff9-a2dd-90b45cb7cb08)

Company: https://www.keypedia.com/companies/freeman-oak-hill-health-system-irb-1/6c2f56b3-f44b-41c9-94bb-908c4ef6ebff

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c